Cover Image

Place of imidazoline receptor agonists in the treatment of arterial hypertension

The review is devoted to one of the most controversial issues of modern antihypertensive therapy - the role of new generation sympatholytics - selective I1-imidazoline receptor agonists (AIRs). In modern European recommendations, AIR (moxonidine rilmenidine), along with other centrally acting drugs...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. V. Nebieridze (Author), A. S. Safaryan (Author), E. I. Ivanova (Author), E. A. Poddubskaya (Author)
Format:	Book
Published:	Столичная издательская компания, 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?
by: D. V. Nebieridze, et al.
Published: (2015)

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?
by: D. V. Nebieridze, et al.
Published: (2015)

Imidazoline receptors agonists: possible mechanisms of endothelioprotection
by: Vladislav O. Soldatov, et al.
Published: (2018)

Theory and practice of selective imidazoline receptor agonist use in Russia
by: N. I. Gaponova, et al.
Published: (2024)

Correction of retinal ischemic injuries by using non-selective imidazoline receptor agonists in the experiment
by: Elena A. Levkova, et al.
Published: (2019)

Molecular Modeling, Synthesis, and Antihyperglycemic Activity of the New Benzimidazole Derivatives – Imidazoline Receptor Agonists
by: Martynov A, et al.
Published: (2024)

POSSIBLE WAYS OF PHARMACOLOGICAL CORRECTION OF ISCHEMIC DAMAGE TO THE LIVER WITH THE AGONIST OF PERIPHERAL IMIDAZOLINE RECEPTORS C7070
by: Anton Dovgan, et al.
Published: (2017)

Not first‐line antihypertensive agents, but still effective-The efficacy and safety of imidazoline receptor agonists: A network meta‐analysis
by: András Érszegi, et al.
Published: (2024)

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016)

The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 1)
by: A. S. Safaryan, et al.
Published: (2019)

COMMENTS ON NEW EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION
by: D. V. Nebieridze
Published: (2016)

An Imidazoline 2 Receptor Ligand Relaxes Mouse Aorta via Off-Target Mechanisms Resistant to Aging
by: Francesc Jiménez-Altayó, et al.
Published: (2022)

LIGAND OF PERIPHERAL IMIDAZOLINE RECEPTORS BASED ON AMIDES OF HETEROCYCLIC ACIDS C7070: EFFECT ON ISHEMIZED TISSUES
by: Anton Dovgan
Published: (2017)

Involvement of Supraspinal Imidazoline Receptors and Descending Monoaminergic Pathways in Tizanidine-Induced Inhibition of Rat Spinal Reflexes
by: Yurika Kino, et al.
Published: (2005)

The Vascular Wall State and Microcirculation Parameters in Patients with Controlled and Uncontrolled Arterial Hypertension
by: V. I. Podzolkov, et al.
Published: (2019)

COMPARATIVE EFFICACY OF LONG-TERM ANTIHYPERTENSIVE MONOTHERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AT THE WORK PLACE
by: О. N. Antropova, et al.
Published: (2016)

THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION
by: I. L. Tepoyan, et al.
Published: (2015)

THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION
by: I. L. Tepoyan, et al.
Published: (2015)

Treatment of Hypertension: Is There a Place for Personalization of the Approach in Modern Recommendations?
by: V. I. Podzolkov, et al.
Published: (2020)

Modelling of chromatographic and electrophoretic behaviour of imidazoline and alpha adrenergic receptors ligands under different acid-base conditions
by: Slavica Oljacic, et al.
Published: (2024)

MODERN POSSIBILITIES OF ACHIEVING TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS IN OUTPATIENT PRACTICE: THE LEADER STUDY RESULTS
by: D. V. Nebieridze, et al.
Published: (2018)

THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION
by: D. B. Nebieridze, et al.
Published: (2015)

THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION
by: D. B. Nebieridze, et al.
Published: (2015)

Synthetic Design and Biological Evaluation of New p53-MDM2 Interaction Inhibitors Based on Imidazoline Core
by: Daniil R. Bazanov, et al.
Published: (2022)

Uric Acid as a Risk Factor for Cardiovascular Diseases
by: A. S. Safaryan, et al.
Published: (2022)

The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2)
by: A. S. Safaryan, et al.
Published: (2020)

The biased apelin receptor agonist, MM07, reverses Sugen/hypoxia-induced pulmonary arterial hypertension as effectively as the endothelin antagonist macitentan
by: Thomas L. Williams, et al.
Published: (2024)

Pharmacoeconomic analysis of thrombopoietin receptor agonists in the treatment of chronic idiopathic thrombocytopenic purpura in adults
by: E. A. Pyadushkina, et al.
Published: (2018)

Transient Arterial Hypertension Induced by Gonadotropin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
by: Loukia Sifaki, et al.
Published: (2019)

GLP-1 Receptor Agonists and Coronary Arteries: From Mechanisms to Events
by: Aurélie Pahud de Mortanges, et al.
Published: (2022)

Partial Least Square and Hierarchical Clustering in ADMET Modeling: Prediction of Blood - Brain Barrier Permeation of α-Adrenergic and Imidazoline Receptor Ligands
by: Katarina Nikolic, et al.
Published: (2013)

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues
by: N. M. Akhmedzhanov, et al.
Published: (2019)

Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension
by: Allan K. N. Alencar, et al.
Published: (2017)

TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY
by: V. I. Podzolkov, et al.
Published: (2015)

TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY
by: V. I. Podzolkov, et al.
Published: (2015)

CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS
by: E. A. Pyadushkina, et al.
Published: (2016)

PLACE AND VALUE OF ENDOVASCULAR AND HYBRID TECHNOLOGIES IN TREATMENT OF LOWER EXTREMITY PERIPHERAL ARTERY DISEASE
by: KH.S. MUKHAMMADIEVA, et al.
Published: (2018)

Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune thrombocytopenia
by: Olga S. Levchenkova, et al.
Published: (2023)

Agonist-Promoted Phosphorylation and Internalization of the Kappa Opioid Receptor in Mouse Brains: Lack of Connection With Conditioned Place Aversion
by: Chongguang Chen, et al.
Published: (2022)

IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS?
by: A. А. Sarycheva, et al.
Published: (2017)